University Hospital, Lille clinical trial pipeline

5 trials changed in the last 30 days: 0 stopped, 2 with notable changes, 3 with minor changes only.

1. Notable

   IFM2021-01 · Teclistamab in Combination · Multiple Myeloma

   Primary completion pushed from Apr 2026 to Jun 2027

   Also in this update: Enrollment closed, study ongoing; Trial sites reduced: 29 → 22 locations

   University Hospital, Lille·Phase 2· NCT05572229· Registry history of NCT05572229 on ClinicalTrials.gov (opens the registry)

   Sep 25, 2026

2. Notable

   INTRUDE · FMRI-based Neurofeedback to Relieve Drug-resistant…INTRUDE · FMRI-based Neurofeedback to Relieve Drug-resistant Auditory Hallucinations

   Primary and study completion pushed from Jul 2026 to Nov 2028

   University Hospital, Lille·Not applicable· NCT04798131· Registry history of NCT04798131 on ClinicalTrials.gov (opens the registry)

   Oct 1, 2026

• Stopped: an ongoing trial was terminated, suspended or withdrawn.
• Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
• Minor: routine progress and housekeeping, such as sites added or enrollment closed.